← Leaderboards
Stephanie Seminara
Massachusetts General Hospital
$24,106,423
Attributed
$24,106,423
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,182,460 · 14
FDA$2,391,635 · 2
By mechanism
P50$22,417,053 · 8
R01$8,709,661 · 3
R37$4,882,608 · 1
U54$3,688,893 · 3
K24$875,880 · 1
Top collaborators
- William F Crowley3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- William F Crowley$27,565,527
- Nelly Pitteloud$2,730,838
- Maria Stamou$403,428
- Ravikumar Balasubramanian$4,018,930
- Xuefang Zhao$1,018,771
Others in their field
Top investigators on “Reproductive”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$124,637,643
- Peter Gordon Gillespie · Oregon Health And Science University$107,804,618
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,236,390
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Walter John Curran · Thomas Jefferson University$66,579,129
Research focus
ReproductiveGeneticPhenotypeMutationGenesResearch PersonnelHypothalamic StructurePhysiologyGrantPathway InteractionsNeuronsGenotypePhysiologicalReceptorKallmann SyndromeInfertilityResponseEndocrineFamilyPositioning AttributeAdultPhysiologic PulseDiagnosticPuberty
Grant awards (76)
The Massachusetts General Hospital Harvard Center for Reproductive Medicine$1,533,189
P50 · FY2025 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$892,586
R37 · FY2025 · HD · contact PI
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches$400,944
P50 · FY2025 · HD · contact PI
Phase 2 Kp-10 in Patients with Hypogonadotropic Hypogonadism$324,996
R01 · FY2025 · FD · contact PI
Core A - Administrative$193,803
P50 · FY2025 · HD · contact PI
The Massachusetts General Hospital Harvard Center for Reproductive Medicine$1,533,189
P50 · FY2024 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$785,188
R37 · FY2024 · HD · contact PI
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches$400,944
P50 · FY2024 · HD · contact PI
Core A - Administrative$193,803
P50 · FY2024 · HD · contact PI
The Massachusetts General Hospital Harvard Center for Reproductive Medicine$1,533,283
P50 · FY2023 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$793,120
R37 · FY2023 · HD · contact PI
Phase 2 Kp-10 in Patients with Hypogonadotropic Hypogonadism$649,997
R01 · FY2023 · FD · contact PI
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches$401,038
P50 · FY2023 · HD · contact PI
Core A - Administrative$193,803
P50 · FY2023 · HD · contact PI
The Massachusetts General Hospital Harvard Center for Reproductive Medicine$1,550,426
P50 · FY2022 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$793,120
R37 · FY2022 · HD · contact PI
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches$418,181
P50 · FY2022 · HD · contact PI
Core A - Administrative$193,803
P50 · FY2022 · HD · contact PI
The Massachusetts General Hospital Harvard Center for Reproductive Medicine$1,619,858
P50 · FY2021 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$793,120
R37 · FY2021 · HD · contact PI
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches$441,413
P50 · FY2021 · HD · contact PI
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977$338,118
R01 · FY2021 · FD · contact PI
Core A - Administrative$200,603
P50 · FY2021 · HD · contact PI
Harvard Reproductive Endocrine Sciences Center$1,732,450
P50 · FY2020 · HD · contact PI
Towards Curative Therapies for Hypogonadotropic Diseases$825,474
R37 · FY2020 · HD · contact PI
Technical Services Core$360,690
P50 · FY2020 · HD · contact PI
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977$337,620
R01 · FY2020 · FD · contact PI
Education Outreach Core$97,025
P50 · FY2020 · HD · contact PI
Harvard Reproductive Endocrine Sciences Center$1,732,450
P50 · FY2019 · HD · contact PI
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977$373,042
R01 · FY2019 · FD · contact PI
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$361,270
R01 · FY2019 · HD · contact PI
Technical Services Core$360,690
P50 · FY2019 · HD · contact PI
Education Outreach Core$97,025
P50 · FY2019 · HD · contact PI
Harvard Reproductive Endocrine Sciences Center$1,732,450
P50 · FY2018 · HD
Technical Services Core$377,567
P50 · FY2018 · HD · contact PI
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977$367,862
R01 · FY2018 · FD · contact PI
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$362,897
R01 · FY2018 · HD · contact PI
Education Outreach Core$52,053
P50 · FY2018 · HD · contact PI
Harvard Reproductive Endocrine Sciences Center$1,732,450
P50 · FY2017 · HD
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$382,780
R01 · FY2017 · HD · contact PI
Technical Services Core$360,688
P50 · FY2017 · HD · contact PI
Education Outreach Core$97,023
P50 · FY2017 · HD · contact PI
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$83,627
R01 · FY2017 · HD · contact PI
Harvard Reproductive Endocrine Sciences Center$1,767,927
P50 · FY2016 · HD
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$454,978
R01 · FY2016 · HD · contact PI
Technical Services Core$336,660
P50 · FY2016 · HD · contact PI
Education Outreach Core$90,562
P50 · FY2016 · HD · contact PI
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human$479,607
R01 · FY2015 · HD · contact PI
Integration of NKB and Kisspeptin Control of GNRH Secret$348,841
P50 · FY2015 · HD · contact PI
Kisspeptin Physiology in Human Reproduction$175,176
K24 · FY2015 · HD · contact PI
Integration of NKB and Kisspeptin Control of GNRH Secret$332,222
P50 · FY2014 · HD · contact PI
Kisspeptin Physiology in Human Reproduction$175,176
K24 · FY2014 · HD · contact PI
Kisspeptin Physiology in the Human$331,256
R01 · FY2013 · HD · contact PI
Integration of NKB and Kisspeptin Control of GNRH Secret$318,448
U54 · FY2013 · HD · contact PI
Kisspeptin Physiology in Human Reproduction$175,176
K24 · FY2013 · HD · contact PI
Kisspeptin Physiology in the Human$349,058
R01 · FY2012 · HD · contact PI
Integration of NKB and Kisspeptin Control of GNRH Secret$329,116
U54 · FY2012 · HD · contact PI
Kisspeptin Physiology in Human Reproduction$175,176
K24 · FY2012 · HD · contact PI
Integration of NKB and Kisspeptin Control of GNRH Secret$369,498
U54 · FY2011 · HD · contact PI
Kisspeptin Physiology in the Human$349,058
R01 · FY2011 · HD · contact PI
Kisspeptin Physiology in Human Reproduction$175,176
K24 · FY2011 · HD · contact PI
Physiologic Roles of GPR54 & Its Metastin: Gatekeepers in Reproductive Cascade$505,489
U54 · FY2010 · HD · contact PI
Kisspeptin Physiology in the Human$363,602
R01 · FY2010 · HD · contact PI
Physiologic Roles of GPR54 & Its Metastin: Gatekeepers in Reproductive Cascade$485,810
U54 · FY2009 · HD · contact PI
Kisspeptin Physiology in the Human$366,929
R01 · FY2009 · HD · contact PI
Establishing the Genetic Etiology for Kallmann Syndrome$154,333
R01 · FY2009 · HD · contact PI
Elucidating the Physiogical Role of GPR54 and its Ligand, Metastin:$500,211
U54 · FY2008 · HD · contact PI
Establishing the Genetic Etiology for Kallmann Syndrome$361,698
R01 · FY2008 · HD · contact PI
Elucidating the Physiogical Role of GPR54 and its Ligand, Metastin:$500,568
U54 · FY2007 · HD · contact PI
Establishing the Genetic Etiology for Kallmann Syndrome$369,080
R01 · FY2007 · HD · contact PI
Establishing the Genetic Etiology for Kallmann Syndrome$380,103
R01 · FY2006 · HD · contact PI
Elucidating the Physiogical Role of GPR54 and its Ligan$344,899
U54 · FY2006 · HD · contact PI
Establishing the Genetic Etiology for Kallmann Syndrome$389,250
R01 · FY2005 · HD
Elucidating the Physiogical Role of GPR54 and its Ligan$334,854
U54 · FY2005 · HD
Establishing the Genetic Etiology for Kallmann Syndrome$389,250
R01 · FY2004 · HD
Establishing the Genetic Etiology for Kallmann Syndrome$389,250
R01 · FY2003 · HD